The U.S. FDA is alerting health care professionals and patients about the risk of thigh bone fractures after surgery with Zimmer Biomet's (NYSE:ZBH) CPT Hip System Femoral Stem. In July, the company ...
Source LinkThe U.S. FDA is alerting health care professionals and patients about the risk of thigh bone fractures after surgery with Zimmer Biomet's (NYSE:ZBH) CPT Hip System Femoral Stem. In July, the company ...
Source Link
Comments